ReviewDiagnostics (Basel, Switzerland)2023

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology.

Shiu-Jau Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.